Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Journal of Medicinal Chemistry
|
July 1, 2026
Engineering Cathepsin S Selective Chemical Probes and Antibody-Drug Conjugates through Substrate Profiling with Unnatural Amino Acids
Maria Łęcka, Oliwia Gorzeń, Natalia Ćwilichowska-Puślecka, et al.
Plos One
|
April 26, 2018
Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction
John D Belcher, Chunsheng Chen, Julia Nguyen, et al.
Frontiers in Medicine
|
May 5, 2023
The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
John D Belcher, Selvaraj Nataraja, Fuad Abdulla, et al.
Haematologica
|
June 1, 2019
A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease
James G McArthur, Niels Svenstrup, Chunsheng Chen, et al.
Blood
|
January 8, 2010
The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice
Robert P Hebbel, Gregory M Vercellotti, Betty S Pace, et al.
The Journal of Biological Chemistry
|
March 16, 2011
CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)
Ranjana Mitra, Zhijun Guo, Monica Milani, et al.
Epigenomics
|
December 23, 2025
Mitochondrial DNA copy number reduction via <i>in vitro TFAM</i> knockout remodels the nuclear epigenome and transcriptome
Phyo W Win, Julia Nguyen, Elly H Shin, et al.
Blood Advances
|
July 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia
Jorge J Castillo, Alberto Guijosa, John N Allan, et al.
Blood
|
September 29, 2023
Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation
Zalaya K Ivy, John D Belcher, Iryna A Khasabova, et al.
American Journal of Hematology
|
March 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia
Jorge J Castillo, Andrew R Branagan, Alberto Guijosa, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Journal of Medicinal Chemistry
|
July 1, 2026
Engineering Cathepsin S Selective Chemical Probes and Antibody-Drug Conjugates through Substrate Profiling with Unnatural Amino Acids
Maria Łęcka, Oliwia Gorzeń, Natalia Ćwilichowska-Puślecka, et al.
Plos One
|
April 26, 2018
Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction
John D Belcher, Chunsheng Chen, Julia Nguyen, et al.
Frontiers in Medicine
|
May 5, 2023
The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
John D Belcher, Selvaraj Nataraja, Fuad Abdulla, et al.
Haematologica
|
June 1, 2019
A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease
James G McArthur, Niels Svenstrup, Chunsheng Chen, et al.
Blood
|
January 8, 2010
The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice
Robert P Hebbel, Gregory M Vercellotti, Betty S Pace, et al.
The Journal of Biological Chemistry
|
March 16, 2011
CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)
Ranjana Mitra, Zhijun Guo, Monica Milani, et al.
Epigenomics
|
December 23, 2025
Mitochondrial DNA copy number reduction via <i>in vitro TFAM</i> knockout remodels the nuclear epigenome and transcriptome
Phyo W Win, Julia Nguyen, Elly H Shin, et al.
Blood Advances
|
July 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia
Jorge J Castillo, Alberto Guijosa, John N Allan, et al.
Blood
|
September 29, 2023
Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation
Zalaya K Ivy, John D Belcher, Iryna A Khasabova, et al.
American Journal of Hematology
|
March 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia
Jorge J Castillo, Andrew R Branagan, Alberto Guijosa, et al.
Page
of 9